LEP and cancer: Abnormal leptin signaling has been documented in several cancers, including those of the breast, endometrium, pancreas, colon, prostate, liver, skin, brain, esophagus, stomach, thyroid gland and ovaries, as well as in leukemia and some bone cancers.